Free Trial
NYSE:HIMS

Hims & Hers Health Q3 2026 Earnings Date & Estimates

Hims & Hers Health logo
$31.62 +0.71 (+2.28%)
As of 09:40 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health is expected to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for November 2, 2026 at 5:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
5:00 PM ET

What Analysts Expect from Hims & Hers Health in Q3 2026

Hims & Hers Health is expected to post earnings of $0.0566 per share on revenue of $892.88 million. In the same quarter a year earlier Hims & Hers Health reported $0.06 per share on revenue of $598.98 million. Hims & Hers Health last reported on August 10, 2026, posting -$0.37 per share and missing the -$0.0498 consensus estimate. Hims & Hers Health has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.0566
Expected Revenue
$892.88 million
Prior-Year EPS
$0.06
Prior-Year Revenue
$598.98 million
Expected EPS Growth
-5.6%
Expected Revenue Growth
+49.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.37 (Missed by -$0.3202)
Last Quarter Revenue
$753.21 million
EPS Beat Rate
4 of last 8 quarters

Hims & Hers Health Q3 2026 Earnings FAQ

Hims & Hers Health (NYSE:HIMS) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Hims & Hers Health's Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Hims & Hers Health to post earnings of $0.0566 per share for Q3 2026.

The consensus revenue estimate for Hims & Hers Health is $892.88 million for Q3 2026.

Hims & Hers Health Earnings Headlines

Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
Hims & Hers Health climbs 10% amid recent volatile trading
See More Hims & Hers Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hims & Hers Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hims & Hers Health and other key companies, straight to your email.

About Hims & Hers Health

Hims & Hers Health (NYSE:HIMS) is a direct-to-consumer telehealth company that provides access to personalized healthcare through its online platforms, Hims and Hers. The company connects consumers with licensed healthcare professionals for virtual consultations, treatment plans and prescription medications where appropriate.

Its services address a range of common health and wellness needs, including sexual health, hair loss, skincare, mental health, weight management and primary care. Hims & Hers offers branded and generic treatments, over-the-counter products, supplements and personal-care products, with services designed for both men and women.

The company was founded in 2016, launched the Hims brand in 2017 and introduced the Hers brand in 2018. Hims & Hers Health became a publicly traded company in 2021 following a business combination with a special purpose acquisition company. Its platform primarily serves consumers in the United States, with an expanding international presence.

Andrew Dudum, a co-founder of the company, serves as chief executive officer. Hims & Hers Health combines digital health technology, clinician networks, pharmacy services and consumer-focused products to provide a more convenient alternative to traditional healthcare access.

View Hims & Hers Health Profile